"""
PharmaRawMaterialCell — API precursor + excipient intake orchestration.

Per ADR-2605250500 §Decision 3 G7 (CWC dual-use precursor monitoring) +
ADR-2605250515 §Decision 3 (per-compound raw material CWC/safety table) +
ADR-2605250545 §Decision 1 (8 supply chain categories — categories 1+2).

Pregel graph (3 nodes):

    receive_supplier_attestation  <-  XRPC: supplier's CoA (Certificate of Analysis)
                                      delivered via @etzhayyim/sdk substrate; supplier DID,
                                      lot identification, identity/purity assays attached
        |
        v
    classify_cwc_and_safety       ->  evaluate against:
                                        OPCW CWC Schedule 1/2/3
                                        Australia Group precursor list
                                        国内 (薬機法 / 化審法 / 麻向法 / 毒劇法 / 消防法 危険物
                                              / 高圧ガス保安法)
                                      → cwc_schedule, safety_class
                                      → if HIGH (acetic anhydride / NaNH₂):
                                          Council Lv6+ ≥ 3 + OPCW declaration verify
                                          OR 危険物取扱主任者 DID co-sign
        |
        v
    emit_raw_material_attest      ->  MST PUT com.etzhayyim.pharma.rawMaterialAttestation
                                      (CWC schedule, safety class, kg-quantity, supplier
                                       DID, Council co-sign URI if applicable)
                                  ->  next-cell message
                                       (typically pharma_api_synthesis for API precursors,
                                        pharma_sterile_fill_finish for excipients/WFI/utility)

Tier: B (Per-Domain).
Murakumo node (proposed): naphtali.
Charter Rider §2(a) risk: HIGH for acetic anhydride (DSCG Step 1, OPCW Schedule 3).
Safety risk: HIGH for NaNH₂ (chlorpheniramine Step 1-2, 消防法 危険物 第3類 + 毒劇法 劇物).
"""

from __future__ import annotations

# ─────────────────────────────────────────────────────────────────────────────
# COUNCIL ACTIVATION GATE (ADR-2605250500 §Decision 3 G3 + G4 + G7)
# ─────────────────────────────────────────────────────────────────────────────
# This cell is scaffold-only until ALL of the following hold:
#
#   1. Council Lv6+ ≥ 3 multisig has attested to the master charter
#      ADR-2605250500 (silen-pharma-review baseline).
#
#   2. QP-equivalent registry CID is set (G4).
#
#   3. 消防法 危険物 取扱主任者 DID is registered for HIGH-safety raw material
#      intake (G2-safety).
#
#   4. OPCW declaration channel is operational for HIGH-§2(a) raw material
#      kg-scale intake (G7).
#
# Any None below → import-time RuntimeError.

COUNCIL_CHARTER_ATTESTATION_TX_HASH: str | None = None
SILEN_PHARMA_BASELINE_REVIEW_CID: str | None = None
QP_EQUIVALENT_REGISTRY_CID: str | None = None
DANGEROUS_GOODS_OFFICER_REGISTRY_CID: str | None = None
OPCW_DECLARATION_CHANNEL_DID: str | None = None

if (
    COUNCIL_CHARTER_ATTESTATION_TX_HASH is None
    or SILEN_PHARMA_BASELINE_REVIEW_CID is None
    or QP_EQUIVALENT_REGISTRY_CID is None
    or DANGEROUS_GOODS_OFFICER_REGISTRY_CID is None
    or OPCW_DECLARATION_CHANNEL_DID is None
):
    raise RuntimeError(
        "pharma_raw_material cell scaffold-only — Council has not (a) attested "
        "the yakushi master charter ADR-2605250500 silen-pharma-review baseline "
        "(G3), or (b) registered the QP-equivalent registry (G4), or (c) "
        "registered the 消防法 危険物 取扱主任者 DID for HIGH-safety raw material "
        "intake (G2-safety: NaNH₂), or (d) established the OPCW declaration "
        "channel DID for HIGH-§2(a) raw material kg-scale intake (G7: acetic "
        "anhydride). Do not deploy."
    )


# ─────────────────────────────────────────────────────────────────────────────
# Pregel super-step skeleton (only reached after the Council gate is removed)
# ─────────────────────────────────────────────────────────────────────────────
#
# from kotodama.organism import PregelCell, RawMaterialIntake, SafetyClassification
#
# class PharmaRawMaterialCell(PregelCell):
#     process_step = "raw-material-intake"
#     pregel_tier = "B"
#     murakumo_node = "naphtali"
#
#     def super_step(self, intake, prior_attestations):
#         # 1. validate inbound intake.supplier_did and CoA URI
#         # 2. classify against OPCW CWC + Australia Group + 国内 + safety
#         # 3. if HIGH risk → require Council Lv6+ co-sign (G3 + G7) or
#         #    safety officer co-sign (G2-safety)
#         # 4. write rawMaterialAttestation; emit downstream
#         #    (pharma_api_synthesis for API precursors;
#         #     pharma_sterile_fill_finish for excipients/utility)
#         raise NotImplementedError("R1+ phase wave implements super_step")
